Opportunity Overview
The U.S. Food and Drug Administration Center for Devices and Radiological Health is seeking Animal Blood, CDRH2026134634 for the Office of Science and Engineering Laboratories Cardiovascular Program. The underlying RFQ is identified in the notice as Solicitation No. 75F40126Q00362.
Deadline
Quotes are due September 18, 2026 at 10:00 AM Eastern Daylight Time.
Scope
The procurement covers donor whole blood from bovine, ovine, and porcine species for hemocompatibility testing and medical-device research, including hemolysis- and thrombosis-related projects. Supplies must satisfy the requirements document governing species availability, minimum draw frequency, blood quality, minimum delivery volumes, anticoagulant type, labeling, quarantine protocol, veterinary oversight, and related quality controls.
Eligibility and Quality Requirements
This acquisition is a total small-business set-aside under NAICS 325414, Biological Product Manufacturing, and PSC 6640, Laboratory Equipment and Supplies. The requirements include AAALAC accreditation and ISO 13485:2016 certification, along with the veterinary oversight and product-control documentation specified in the solicitation.
Funding / Contract Value
No fixed maximum contract value is stated in the public notice.
Qualification Guidance
Potential respondents should review the current combined synopsis/solicitation and Attachment 1 in full and confirm that they can meet every species, quality, handling, accreditation, certification, delivery, and quotation requirement before responding.